MSA Capital is a global investment firm that focuses on private venture and growth assets. Founded in 2014, the firm manages over USD 2 billion and invests in highly innovative and disruptive companies. Their investment strategy emphasizes backing leading entrepreneurs in biotechnology and enterprise-facing core technology. They aim to identify and support companies that are poised to significantly impact their respective industries.
Preferred startup development maturity for initial funding deployment.
biotechnology, enterprise-facing core technology
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...